Annual report
4887.TEDINET S100W39J
Period2024-04-01 → 2025-03-31
Filed2025-06-24
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 130
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥189.0bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥176.9bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥163.7bn | 2022-04-01 → 2023-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥193.8bn | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥18.6bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥3.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥18.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥15.8bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥36.2bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥12.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥13.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥12.7bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥28.3bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥12.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥9.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥12.8bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | −¥41.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥354.6bn | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥382.0bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥364.2bn | at 2023-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥349.5bn | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥180.8bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥164.0bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥173.9bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥218.0bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥212.7bn | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥173.9bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥212.7bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥201.6bn | at 2023-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥190.1bn | at 2022-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥38.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥26.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥33.1bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥47.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥27.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥23.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥13.0bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥34.3bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | ¥6.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥23.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥27.1bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥30.4bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥32.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥2.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥96.54 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥104.22 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥96.42 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-215.18 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥96.25 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥103.93 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥96.2 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-215.18 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,505.86 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,618.32 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,534.89 | at 2023-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,446.77 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 49.0% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.7% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.4% | at 2023-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 54.4% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 6.2% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.6% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.5% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -13.8% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 3,310 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 3,482 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 3,393 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 2,968 | at 2022-03-31d | Cons. | Number of employees |
| Revenue | ¥18.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥15.4bn | 2023-04-01 → 2024-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥9.1bn | 2022-04-01 → 2023-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥2.2bn | 2021-04-01 → 2022-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥14.8bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥12.6bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥14.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥12.5bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.9bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥230m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥10.9bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.9bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥11.3bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥18.0bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥6.9bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥30.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥233.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥224.0bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥188.3bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥192.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥71.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥33.8bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥162.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥190.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥178.0bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥176.6bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.4bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥747m | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥90.97 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.34 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.88 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-230.38 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.7 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.95 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥52.76 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥105 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥130 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥130 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥130 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,404.19 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,444.58 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,351.66 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,342.16 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 69.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.3% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.8% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.9% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -34.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 131,469,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 131,410,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 131,374,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 131,374,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 98 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 77 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 73 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 67 | at 2022-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 1
| Segment | Item | Period | Value |
|---|---|---|---|
| Manufacturing And Sales Of Pharmaceuticals Etcreportable segment | employees | at 2025-03-31 | 3310 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,527
| Item | Context | Value | Unit |
|---|---|---|---|
| Diluted earnings per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 90.70 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 0.918 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 0.943 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.847 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 0.694 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration_NonConsolidatedMember | -0.343 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.039 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.098 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.064 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 23.0 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 14.6 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 21.8 | |
| Payout ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Payout ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.819 | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.316 | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.583 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 67 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 73 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 77 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 98 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 16 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 17 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 14 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 12 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.858 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.731 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.200 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.214 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.020 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.079 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.525 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.502 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E36190-000ManufacturingAndSalesOfPharmaceuticalsEtcReportableSegmentMember | 3310 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E36190-000ManufacturingAndSalesOfPharmaceuticalsEtcReportableSegmentMember | 321 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 98 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 12 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 44.4 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8.8 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8857000 | JPY |
| Ratio of female employees in managerial positions metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | 0.103 | |
| All employees ratio of male employees taking childcare leave metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | 0.462 | |
| All employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | 0.756 | |
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | 0.782 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | 0.615 | |
| Ratio of female employees in managerial positions metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | 0.067 | |
| All employees ratio of male employees taking childcare leave metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | 0.455 | |
| All employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | 0.685 | |
| Regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | 0.685 | |
| Non regular employees differences in wages between male and female employees metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | 0.862 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |